Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.26379 | 51 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.21101 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.21588 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.11422 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.16465 | 50 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.30005 | 50 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.32558 | 51 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.19286 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.18934 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.19005 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.20139 | 50 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.19031 | 51 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.20812 | 50 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.20389 | 50 |